Objective: The hypoxia inducible factor (HIF)-1 pathway signalling has a protective effect against ischemia/reperfusion injury. The prolyl-hydroxylase inhibitor Dimethyloxalylglycine (DMOG) activates the HIF-1 pathway by stabilizing HIF-1Į. In a rat model of brain death (BD)-associated donor heart dysfunction we tested the hypothesis that a pre-treatment of brain-dead donors with DMOG results in a better graft heart condition. Additionally, compared to brain-dead group, DMOG treatment moderated the proapoptotic changes in the gene and protein expression.
INTRODUCTION
Heart transplantation is the gold standard treatment of end-stage heart failure, presenting excellent results on both short and long term basis [1] . The main limiting factor of organ donation is the availability of suitable organs, meanwhile donor pool is limited to brain-dead donors. Though optimal myocardial preservation is a prerequisite to preserve early allograft function, brain death (BD) itself appears to induce severe changes on the heart function to such an extent, that potential donors must be excluded from transplantation because of emerging hemodynamic instability and primary cardiac dysfunction [2, 3] . Herniation of the brain stem induces a catecholamine storm with an extreme circulatory load, followed by neurohormonal dysfunction with a rapid loss of vasomotoric tone [4] . Abrupt vasodilatation due to circulatory regulational disturbances causes a prominent reduction of coronary blood flow and may result in ischemic injury of the donor heart [5, 6] . The ischemic period activates the hypoxia pathway of the cells via the hypoxia inducible factor (HIF)-1 and its subsequent target genes, such as heme oxygenase (HO)-1, glucose transporter (GLUT)-1, and vascular endothelial growth factor (VEGF). As a result, substrates and enzymes for the anaerobe metabolism are provided, and cell survival is ensured.
HIF-1 plays a key role in the regulation of genes responsible for hypoxia adaptation.
Though its role in different cellular mechanisms (apoptosis, autophagy) is not yet fully revealed, the activation of HIF-1 improves the ischemic injury of cardiac cells in cell culture [7] , and attenuates myocardial ischemia/reperfusion (I/R) injury [8, 9] .
Hearts from brain-dead donors exposed to an ischemic event additionally to the transplantational I/R injury, experience a more intense inflammatory response, ϰ including the production of cytokines and reactive oxygen and nitrogen species (ROS/RNS), causing endothelial cell dysfunction, disturbance in graft microcirculation, neutrophil extravasation induced inflammatory cascade activation, thus leading to parenchymal tissue damage in the graft [10] [11] [12] and ultimately to an increased rate of graft rejection.
Prolyl-4 hydroxylases (PHDs) act as cellular oxygen sensors, and they are the main regulators of (HIF) -1 heterodimer availability. They are responsible for the posttranslational HIF-1Į hydroxylation under normoxigenic conditions, by targeting the subunit for the von Hippel Lindau tumor suppressor protein E3 ubiquitin ligase complex, thus leading to the degradation of HIF-1Į (Figure 1 ) [13] .
Dimethyloxallylglycine (DMOG) is the non-selective inhibitor of PHDs. Based on the previously described relations, the aim of the present study was to test the hypothesis that PHD inhibition, by a single dose of DMOG treatment in brain-dead donor rats improves in vivo left ventricular (LV) graft function after a heart transplantation, using our well established model [10, 14] .
METHODS
See online supplement for further details.
Animals
Male Lewis rats (250-350g; Charles River, Sulzfeld, Germany) were housed in a room at a constant temperature of 22±2ºC with 12h light/dark cycles and were fed a standard laboratory rat diet with water ad libitum. 
Experimental groups and timeline
Following a baseline hemodynamic measurement, rats were randomly assigned to three groups: (1) Control group (n=11): sham operated animals without BD induction;
(2) Brain-dead group (n=7): after BD induction rats were injected with a vehicle (1ml/kg i.v. physiologic saline); (3) Brain-dead+DMOG group (n=7): after BD induction rats were injected with DMOG (30mg/kg; 1ml/kg i.v.). The experimental protocol is shown in Figure 2 . Hemodynamic measurements were performed before BD induction, after the induction phase at T=0h and 5 hours later at T=5h. The hearts were then perfused with a cold (4°C) preservation solution (Custodiol), explanted, stored at 4°C Custodiol and then heterotopically transplanted with an ischemic time adjusted to 1h. The LV function was measured after a reperfusion time standardized to 1.5h. The dose of DMOG was chosen on the basis of our pilot studies and data from literature [9, 15, 16] .
Model of Brain Death
After being anesthetized with sodium pentobarbital (60mg/kg, intraperitoneally), the rats were endotracheally intubated and ventilated by a rodent respirator. 
5.

Model of Heterotopic Heart Transplantation
The transplantations, as previously described [10] , were performed in isogenic Lewis to Lewis rat strain, therefore no organ rejection could be expected. The superior and inferior caval veins and the pulmonary veins were tied en masse with a suture and the heart was immediately placed into cold (4ºC) Custodiol solution [19, 20] . The aorta and the pulmonary artery of the donor heart were correspondingly anastomosed end to side to the abdominal aorta and the vena cava of the recipient rat. The ischemic time was adjusted to 1h. After completion of the anastomoses, the heart was reperfused with blood in situ, and the reperfusion time was standardized to 1.5h.
Measurement of Left-Ventricular Function of the Graft
One and a half hours after transplantation, a 3F latex balloon catheter (Edwards Lifesciences Corporation, Irvine, CA, USA) was introduced into the left-ventricle via the apex to determine LV systolic pressure, LV diastolic pressure, dP/dt max and dP/dt min by a Millar micromanometer (Millar Instruments, Houston, TX, USA) at different LV volumes. From this data, LV pressure-volume relationships were constructed.
ϴ
7.
Histopathological Process
Heart samples from each experimental group were fixed in buffered paraformaldehyde solution (4%) and embedded in paraffin. Then, 5-ȝm-thick sections were placed on adhesive slides. Morphometric analysis was performed for inflammation and necrosis on hematoxylin and eosin stained sections. The evaluation was conducted by an investigator blinded to the experimental groups. The evaluation was performed by scoring according to the grade 0-3 under a light optical microscope with nine or ten sections from each sample.
8.
Terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) staining
TUNEL staining was performed to detect DNA-strand breaks in the myocardial cells of the left ventricle. TUNEL-positive cells were counted in four fields (characterizing each specimen) under a fluorescence microscope, and an average value was calculated for each experimental group. The evaluation was conducted by an investigator blinded to the experimental groups. Mean values were calculated again for each experimental group, and then were compared.
Quantitative Real-Time Polymerase Chain-Reaction (PCR)
Total RNA was isolated from the grafts hearts and then reverse transcription was 
11.
Statistical analysis
All data is tested for normality (Shapiro-Wilk) and expressed as mean ± standard error of the mean (SEM). Intergroup comparisons were performed by using one-way analysis of variance (ANOVA) with Tukey's post hoc test. Differences were considered significant when p<0.05.
RESULTS
LV Cardiac function of donor hearts after brain death
Before the induction of BD (baseline conditions) no significant difference was measured in the hemodynamic parameters of the different groups (data not shown).
Mean arterial pressure showed a constant decrease in both brain-dead groups ( Figure 3A) . Compared either to its baseline or to control group, 5 hours of BD was associated with significantly decreased systolic performance and with an impaired ϭϬ cardiac relaxation. DMOG treatment significantly increased the load-independent contractility parameter (E' max ) and improved LV stiffness (slope of EDPVR) of the hearts of brain-dead donors, compared to the untreated brain-dead group (Table 1) .
LV function of the heart grafts
Significantly decreased LV systolic pressure, developed LV pressure and dP/dt max were found in both brain-dead groups, when compared to the control rats, indicating decreased systolic function, which was significantly improved by DMOG treatment ( Figures 3B, C, D) . Compared to control, impaired ventricular relaxation was observed in hearts from brain-dead donors. DMOG treatment led to significantly increased dP/dt min and to a lower Tau index ( Figures 3E, F) . LV end-diastolic pressure, as a marker of the standardized balloon-catheter measurements (data not shown) did not show a major difference amongst the experimental groups.
Inflammatory changes of the heart grafts
Semiquantitative histological analysis of the tissue sections revealed a slight infiltration of inflammatory cells, rare necrosis and mild edema in the control group.
Similar results were found in the heart grafts after DMOG treatment, while in contrast, extensive inflammation with marked inflammatory cell infiltration, and necrosis were seen in the brain-dead group (Figures 4A-E) . A significant up-regulation of transcription factors NF-kB and TNF-Į was detected in the brain-dead group when compared to the control group. DMOG treatment significantly decreased the up- 
Expressional analysis of the HIF-1 pathway in the heart grafts
Quantitative real-time PCR revealed an up-regulation of the HIF-1Į mRNA expression in both groups with BD compared to control group, but it only reached a significant level in the DMOG-treated brain-dead group. In the expression of the HIF target genes HO-1, GLUT-1, and VEGF no difference was observed in the braindead group versus the control group, but a considerable up-regulation of these genes was detected after DMOG treatment. Compared to control, BD did not alter the protein levels of HIF-1Į, DMOG treatment caused a 3-fold increase in it.
Densitometric analysis of the HO-1 bands showed a significant 1.9 fold increase in the brain-dead group compared to control, DMOG treatment further increased its level to 2.5 fold. GLUT-1 protein expression was significantly increased by DMOG treatment, in comparison to control and brain-dead groups (Figures 6A-H) .
ϭϮ
DISCUSSION
In this study the beneficial effect of DMOG pre-treatment against global I/R injury was assessed through a rat model of heterotopic cardiac transplantation using heart grafts from brain-dead donors.
Experimental models demonstrate the widely discussed pathophysiologic consequences of BD [5, 21] and discuss the possible underlying mechanisms, such as catecholamine storm during Cushing-reaction, followed by arterial spasm causing insufficient blood perfusion, or hormonal depletion with abrupt vasodilatation and sudden drop of aortic and coronary blood-pressure [22] [23] [24] [25] . In agreement with these findings and in spite of the regularly injected volume, in five hours run MAP significantly decreased along with the LV pressures and load dependent contractility parameters in the brain-dead group (Table 1) However, our results show a maintained E' max of ESPVR in the DMOG group, compared to brain-dead group (Table 1) . After hypothermic storage and 1.5 hours of reperfusion transplanted hearts from brain-dead donors showed significantly lower contractility and relaxation, which was significantly improved by DMOG pre-treatment (Figure 3 ). In line with these observations increased DNA strand breakage, upregulated caspase-3 and TNFĮ with down-regulated Bcl-2 levels were detected in graft hearts from brain-dead donors following transplantation (caused by the nocuous effect of BD and by the additional I/R injury during transplantation). These changes were moderated due to the advantageous effect of DMOG in the pre-treated group
(Figures 4-5).
The mechanisms behind the cardioprotective effects of DMOG against I/R injury are based on the inhibition of the oxygen-sensor PHDs (Figure 1 ). In the absence of oxygen, PHDs are no longer active and the unmodified HIF-1Į accumulates.
Dimerising with the constitutive HIF-1ȕ (also known as aryl hydrocarbon receptor nuclear translocator: ARNT), they form HIF-1 heterodimer (a transcription factor of genes participating in tissue response to hypoxia [32]), which limits ischemic or post-ϭϰ ischemic injury (HO-1, GLUT-1, VEGF, iNOS) [8] . After transplantation, brain-dead donors treated with DMOG showed a significant up-regulation of HIF-1Į expression compared to the control group. We also found an up-regulation of HIF-1Į mRNA after DMOG treatment compared to control group. However, as there was no difference found when compared to the brain-dead group, this increase could be accounted to the circulatory insufficiency due to BD. 
Conclusions
To the best of our knowledge, our study is the first that records the cardioprotective effect of a pharmacological preconditioning with dimethyloxalylglycine on the donor heart function under BD conditions, and on the LV graft function after transplantation.
The treatment of brain-dead heart donors with DMOG resulted in a significantly better left-ventricular function after the transplantation. All in all, our results support the view that preconditioning through the inhibition of oxygen sensors, and through the activation of HIF-1 pathway is, potentially, at least in part, associated with a protective role against I/R injury in the myocardium.
ϭϲ
Study limitations
The model of heterotopic heart transplantation also has certain limitations. The leftventricle beats in an unloaded condition (e.g. ventricles are perfused via the coronary circulation, but they do not eject) which on one hand allows a faster recovery after transplantation, and on the other hand leads to a time-dependent mechanical deterioration and atrophy (though it does not occur in 24h) [42] . The influence of prolonged anesthesia on the donor cardiac function shall also be considered a limitation of the model of BD as it deviates from the clinical setting of most donors.
The brief period of reperfusion (1.5 hrs) limits conclusions regarding the effects of DMOG to early recovery of donor function from BD-associated and I/R-induced injuries. Prudent interpretation of the findings obtained from this animal model is required for the extrapolation to humans.
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